BridgeBio Pharma
BBIO
$27.83
Share price
0.32%
Change (1 day)
103.44%
Change (1 year)
Categories
Operating Margin for BridgeBio Pharma (BBIO)
Operating Margin as of May 2024 (TTM): -8,875.20%
According to BridgeBio Pharma 's latest financial reports and stock price the company's current Operating Margin is -8,875.20%. At the end of 2022 the company had an Operating Margin of -624.17%.
Operating Margin history for BridgeBio Pharma from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -624.17% | -25.8% |
| 2021 | -841.20% | -86.27% |
| 2020 | -6,127.87% | 761.26% |
| 2019 | -711.50% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -99.59% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | -5.45% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.